THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.

Andrew J PaladinoJaneane N AndersonRebecca A KrukowskiTeresa WatersMehmet KocakCarolyn GraffRyan BlueTameka N JonesJoanne BuzagloGregory VidalLee SchwartzbergIlana Graetz

Published in: BMC health services research (2019)

NCT03592771. Prospectively registered on July 19, 2018.

Keyphrases

study protocol
randomized controlled trial
early stage
clinical trial
open label
smoking cessation
type diabetes
mesenchymal stem cells
skeletal muscle
chemotherapy induced